High incidence of skin rash in patients with hairy cell leukemia treated with cladribine

被引：20
作者：
Ganzel, Chezi [1 ]
Gatt, Moshe E. [1 ]
Maly, Alexander [2 ]
Ben-Yehuda, Dina [1 ]
Goldschmidt, Neta [1 ]
机构：
[1] Hadassah Hebrew Univ Med Ctr, Dept Hematol, Jerusalem, Israel
[2] Hadassah Hebrew Univ Med Ctr, Dept Pathol, Jerusalem, Israel
来源：
LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 06期
关键词：
Hairy cell leukemia; cladribine; (2-chlorodeoxyadenosine; 2-CdA); lymphopenia; drug hypersensitivity; CUTANEOUS REACTIONS; ADVERSE-REACTIONS; FOLLOW-UP; TRIMETHOPRIM-SULFAMETHOXAZOLE; HYPERSENSITIVITY REACTIONS; INFECTIOUS-MONONUCLEOSIS; DRUG HYPERSENSITIVITY; HOSPITALIZED-PATIENTS; COMPLETE REMISSION; NEUTROPENIC FEVER;
D O I：
10.3109/10428194.2011.635864
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treatment of hairy cell leukemia (HCL) with cladribine induces durable remissions. Common toxicities are myelosuppression and immunosuppression with low counts of CD4+ T cells. Skin rash (SR) is seldom described. We collected clinical and laboratory data of 35 patients with HCL treated in Hadassah between January 1999 and February 2010, in order to evaluate the frequency and characteristics of SR after treatment with cladribine. We found a high frequency of SR in our group of patients (18/35 patients, 51%), mostly related to febrile neutropenia and concomitant treatment with penicillins/trimethoprim-sulfamethoxazole (TMP-SMZ). The lymphocyte count was low in all patients with SR. We conclude that patients with HCL treated with cladribine have an increased rate of drug hypersensitivity, possibly due to T-cell imbalance induced by cladribine. Since TMP-SMZ and penicillins are related to SR in most cases and are important in the management of patients with HCL, a desensitization protocol should be considered. Rechallenge may be safe after immune reconstitution.
引用
收藏
页码：1169 / 1173
页数：5
相关论文
共 38 条
[1]   General considerations on rapid desensitization for drug hypersensitivity - a consensus statement [J].
Cernadas, J. R. ;
Brockow, K. ;
Romano, A. ;
Aberer, W. ;
Torres, M. J. ;
Bircher, A. ;
Campi, P. ;
Sanz, M. L. ;
Castells, M. ;
Demoly, P. ;
Pichler, W. J. .
ALLERGY, 2010, 65 (11) :1357-1366
[2]   Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol [J].
Chubar, Y ;
Bennett, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (05) :768-770
[3]   Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study [J].
Cook, S. ;
Vermersch, P. ;
Comi, G. ;
Giovannoni, G. ;
Rammohan, K. ;
Rieckmann, P. ;
Sorensen, P. Soelberg ;
Hamlett, A. ;
Miret, M. ;
Weiner, J. ;
Viglietta, V. ;
Musch, B. ;
Greenberg, S. J. .
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (05) :578-593
[4]   CUTANEOUS DISEASE AND DRUG-REACTIONS IN HIV-INFECTION [J].
COOPMAN, SA ;
JOHNSON, RA ;
PLATT, R ;
STERN, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (23) :1670-1674
[5]   SOME ADVERSE REACTIONS TO ALLOPURINOL MAY BE MEDIATED BY LYMPHOCYTE-REACTIVITY TO OXYPURINOL [J].
EMMERSON, BT ;
HAZELTON, RA ;
FRAZER, IH .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :436-440
[6]   Extended follow-up of patients with hairy cell leukemia after treatment with cladribine [J].
Goodman, GR ;
Burian, C ;
Koziol, JA ;
Saven, A .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :891-896
[7]   How I treat hairy cell leukemia [J].
Grever, Michael R. .
BLOOD, 2010, 115 (01) :21-28
[8]   Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution [J].
Grey, MR ;
Flanagan, MG ;
Kelsey, PR .
CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (02) :111-113
[9]   Purpuric rash following treatment with 2-chlorodeoxyadenosine [J].
Hendrick, A .
CLINICAL AND LABORATORY HAEMATOLOGY, 2001, 23 (01) :67-68
[10]   Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation? [J].
Jappe, U. .
ALLERGY, 2007, 62 (12) :1474-1475
1234